United States Biotechnology & Medical Research

Sana Biotechnology Inc (SANA)

Track

Track

Sana Biotechnology Inc. experienced multiple divestment activities throughout late 2024 and early 2025. The most recent transactions occurred on February 18, 2025, involving proposed sales by officers. These patterns reflect consistent liquidation efforts by various stakeholders, including directors and former executives, over the preceding months, with no recorded buying activity during this period.
Ticker: SANA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Sana Biotechnology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
74.94
Quantity 26,324 +21.4%
Value US$3,170,391
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
6.71
Quantity 164,912 -3.5%
Value US$1,106,560
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
6.50
Quantity 25,000 -0.5%
Value US$162,500
3.6
FMR LLC See Remark 1 Large shareholder
Transaction date
Sale
Price
6.11
Quantity 100,000 -2.1%
Value US$611,000
Hardy Nathan Former CFO
Transaction date
Proposed sale
Price
2.50
Quantity 91,607
Value US$229,018
NATHAN HARDY Former CFO
Transaction date
Proposed sale
Price
2.50
Quantity 25,933
Value US$64,960
NATHAN HARDY Officer Officer
Transaction date
Proposed sale
Price
3.95
Quantity 45,796
Value US$180,807
Mulligan Richard Non-Executive Director
Transaction date
Planned sale
Price
3.89
Quantity 150,000 -5.3%
Value US$583,170
RICHARD MULLIGAN Director Non-Executive Director
Transaction date
Proposed sale
Price
4.09
Quantity 150,000
Value US$613,500
Mulligan Richard Non-Executive Director
Transaction date
Planned sale
Price
4.08
Quantity 150,000 -5.0%
Value US$612,570
RICHARD MULLIGAN Director Non-Executive Director
Transaction date
Proposed sale
Price
4.09
Quantity 150,000
Value US$613,500
3.0
Yang Patrick Y Non-Executive Director
Transaction date
Sale
Price
9.45
Quantity 25,000 -14.3%
Value US$236,300
3.3
NELSEN ROBERT Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.50
Quantity 727,272 +6.2%
Value US$3,999,996
3.3
NELSEN ROBERT Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.50
Quantity 727,272 +6.2%
Value US$3,999,996
3.3
NELSEN ROBERT Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.50
Quantity 363,637 +3.5%
Value US$2,000,004
CRANDELL KEITH Large shareholder
Transaction date
Purchase
Price
5.50
Quantity 727,272 +6.2%
Value US$3,999,996
CRANDELL KEITH Large shareholder
Transaction date
Purchase
Price
5.50
Quantity 727,272 +6.2%
Value US$3,999,996
CRANDELL KEITH Large shareholder
Transaction date
Purchase
Price
5.50
Quantity 363,637 +3.5%
Value US$2,000,004
Hordo Christian EVP, Chief Business Officer Officer
Transaction date
Planned sale
Price
4.00
Quantity 75,000 -8.0%
Value US$300,098
3.0
Yang Patrick Y Non-Executive Director
Transaction date
Purchase
Price
7.30
Quantity 28,000 +19.1%
Value US$204,400
MacDonald James J. EVP & General Counsel Officer
Transaction date
Planned sale
Price
6.28
Quantity 333 -0.1%
Value US$2,091
AGARWAL SUNIL EVP, Head of Development & CMO Officer
Transaction date
Planned sale
Price
26.00
Quantity 1,627 -0.1%
Value US$42,302
AGARWAL SUNIL EVP, Head of Development & CMO Officer
Transaction date
Planned sale
Price
26.07
Quantity 58,373 -3.6%
Value US$1,521,755
Hordo Christian EVP, Chief Business Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 1,477 -0.2%
Value US$36,925
Bilenker Joshua H. Non-Executive Director
Transaction date
Purchase
Price
25.00
Quantity 20,000 +inf%
Value US$500,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-18 2025-02-18 PrS Proposed sale
CHRISTIAN HORDO & KATHARINE HORDO

Officer

Officer
33,423
343.04
US$2,075,660 		33,423 343.04 US$2,075,660
2025-01-16 2025-01-16 PrS Proposed sale
CHRISTIAN HORDO & KATHARINE HORDO

Officer

Officer
90,701
240.73
US$570,748 		90,701 240.73 US$570,748
2025-01-10 2025-01-08 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
26,324 +21.4%
74.94
US$3,170,391 		26,324 +21.4% 74.94 US$3,170,391
2025-01-10 2025-01-08 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
164,912 -3.5%
6.71
US$1,106,560 		164,912 -3.5% 6.71 US$1,106,560
2025-01-10 2025-01-08 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
25,000 -0.5%
6.50
US$162,500 		25,000 -0.5% 6.50 US$162,500
2025-01-10 2025-01-08 S Sale
3.6
FMR LLC

See Remark 1

Large shareholder
100,000 -2.1%
6.11
US$611,000 		100,000 -2.1% 6.11 US$611,000
2024-12-16 2024-12-16 PrS Proposed sale
CHRISTIAN HORDO & KATHARINE HORDO JT TEN

Officer

Officer
75,000
1.89
US$141,750 		75,000 1.89 US$141,750
2024-11-26 2024-11-26 PrS Proposed sale
Hardy Nathan

Former CFO
91,607
2.50
US$229,018 		91,607 2.50 US$229,018
2024-11-25 2024-11-25 PrS Proposed sale
NATHAN HARDY

Former CFO
25,933
2.50
US$64,960 		25,933 2.50 US$64,960
2024-10-21 2024-10-21 PrS Proposed sale
NATHAN HARDY

Officer

Officer
45,796
3.95
US$180,807 		45,796 3.95 US$180,807
2024-09-26 2024-09-25 PlS Planned sale
Mulligan Richard
Non-Executive Director
150,000 -5.3%
3.89
US$583,170 		150,000 -5.3% 3.89 US$583,170
2024-09-25 2024-09-25 PrS Proposed sale
RICHARD MULLIGAN

Director

Non-Executive Director
150,000
4.09
US$613,500 		150,000 4.09 US$613,500
2024-09-26 2024-09-24 PlS Planned sale
Mulligan Richard
Non-Executive Director
150,000 -5.0%
4.08
US$612,570 		150,000 -5.0% 4.08 US$612,570
2024-09-24 2024-09-24 PrS Proposed sale
RICHARD MULLIGAN

Director

Non-Executive Director
150,000
4.09
US$613,500 		150,000 4.09 US$613,500
2024-03-11 2024-03-08 S Sale
3.0
Yang Patrick Y
Non-Executive Director
25,000 -14.3%
9.45
US$236,300 		25,000 -14.3% 9.45 US$236,300
2024-02-12 2024-02-08 B Purchase
3.3
NELSEN ROBERT
Non-Executive Director Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
3.3
NELSEN ROBERT
Non-Executive Director Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
3.3
NELSEN ROBERT
Non-Executive Director Large shareholder
363,637 +3.5%
5.50
US$2,000,004 		363,637 +3.5% 5.50 US$2,000,004
2024-02-12 2024-02-08 B Purchase
CRANDELL KEITH
Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
CRANDELL KEITH
Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
CRANDELL KEITH
Large shareholder
363,637 +3.5%
5.50
US$2,000,004 		363,637 +3.5% 5.50 US$2,000,004
2024-02-12 2024-02-08 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
727,272 +6.2%
5.50
US$3,999,996 		727,272 +6.2% 5.50 US$3,999,996
2024-02-12 2024-02-08 B Purchase
ARCH Venture Fund X, L.P.
Large shareholder
363,637 +3.5%
5.50
US$2,000,004 		363,637 +3.5% 5.50 US$2,000,004
2023-12-18 2023-12-15 PlS Planned sale
Hordo Christian

EVP, Chief Business Officer

Officer
75,000 -8.0%
4.00
US$300,098 		75,000 -8.0% 4.00 US$300,098
2023-12-15 2023-12-15 PrS Proposed sale
CHRISTIAN HORDO & KATHARINE HORDO JT TEN

Officer

Officer
75,000
3.99
US$299,250 		75,000 3.99 US$299,250
2023-06-08 2023-06-07 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
22,760 -1.6%
6.24
US$142,016 		22,760 -1.6% 6.24 US$142,016
2023-06-08 2023-06-07 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
177,240 -1.6%
6.24
US$1,105,924 		177,240 -1.6% 6.24 US$1,105,924
2023-06-07 2023-06-07 PrS Proposed sale
FLAGSHIP VENTURES FUND V, L.P.

Affiliate
310,170
6.39
US$1,981,986 		310,170 6.39 US$1,981,986
2023-06-07 2023-06-07 PrS Proposed sale
Flagship V Venturelabs RX Fund, L.P.

Affiliate
39,830
6.39
US$254,514 		39,830 6.39 US$254,514
2023-06-08 2023-06-06 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
22,297 -1.6%
6.31
US$140,607 		22,297 -1.6% 6.31 US$140,607
2023-06-08 2023-06-06 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
181,461 -1.6%
6.31
US$1,144,311 		181,461 -1.6% 6.31 US$1,144,311
2023-05-26 2023-05-26 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
9,330 -0.7%
6.23
US$58,093 		9,330 -0.7% 6.23 US$58,093
2023-05-26 2023-05-26 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
72,670 -0.7%
6.23
US$452,480 		72,670 -0.7% 6.23 US$452,480
2023-05-26 2023-05-25 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
13,127 -0.9%
6.35
US$83,385 		13,127 -0.9% 6.35 US$83,385
2023-05-26 2023-05-25 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
102,245 -0.9%
6.35
US$649,481 		102,245 -0.9% 6.35 US$649,481
2023-05-26 2023-05-24 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
39,580 -2.7%
6.57
US$259,851 		39,580 -2.7% 6.57 US$259,851
2023-05-26 2023-05-24 S Sale
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
308,290 -2.7%
6.57
US$2,023,986 		308,290 -2.7% 6.57 US$2,023,986
2023-05-24 2023-05-24 PrS Proposed sale
Flagship V Venturelabs RX Fund, L.P.

affiliate
85,334
7.01
US$598,191 		85,334 7.01 US$598,191
2023-05-24 2023-05-24 PrS Proposed sale
FLAGSHIP VENTURES FUND V, L.P.

affiliate
664,666
7.01
US$4,659,309 		664,666 7.01 US$4,659,309
2023-05-24 2023-05-24 PrS Proposed sale
FLAGSHIP VENTURES FUND V, L.P.

affiliate
85,334
7.01
US$598,191 		85,334 7.01 US$598,191
2022-03-22 2022-03-21 B Purchase
3.0
Yang Patrick Y
Non-Executive Director
28,000 +19.1%
7.30
US$204,400 		28,000 +19.1% 7.30 US$204,400
2022-02-23 2022-02-18 PlS Planned sale
MacDonald James J.

EVP & General Counsel

Officer
333 -0.1%
6.28
US$2,091 		333 -0.1% 6.28 US$2,091
2021-09-17 2021-09-16 PlS Planned sale
AGARWAL SUNIL

EVP, Head of Development & CMO

Officer
1,627 -0.1%
26.00
US$42,302 		1,627 -0.1% 26.00 US$42,302
2021-09-17 2021-09-15 PlS Planned sale
AGARWAL SUNIL

EVP, Head of Development & CMO

Officer
58,373 -3.6%
26.07
US$1,521,755 		58,373 -3.6% 26.07 US$1,521,755
2021-09-14 2021-09-10 PlS Planned sale
Hordo Christian

EVP, Chief Business Officer

Officer
1,477 -0.2%
25.00
US$36,925 		1,477 -0.2% 25.00 US$36,925
2023-02-17 2021-02-03 B Purchase
Bilenker Joshua H.
Non-Executive Director
20,000 +inf%
25.00
US$500,000 		20,000 +inf% 25.00 US$500,000
Explore more

More insider trading research around Sana Biotechnology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America